Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

HIV drug development: the next 25 years.

Flexner C.

Nat Rev Drug Discov. 2007 Dec;6(12):959-66. Review.

2.

The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets.

Turpin JA.

Expert Rev Anti Infect Ther. 2003 Jun;1(1):97-128. Review.

PMID:
15482105
3.

The design of drugs for HIV and HCV.

De Clercq E.

Nat Rev Drug Discov. 2007 Dec;6(12):1001-18. Review.

4.

Current developments in anti-HIV/AIDS gene therapy.

Tsygankov AY.

Curr Opin Investig Drugs. 2009 Feb;10(2):137-49. Review.

PMID:
19197791
5.

Part XV. Antiretroviral therapy for human immunodeficiency virus infection.

Stephens JR, Rathbun RC, Lockhart SM, Bronze MS, Greenfield RA.

J Okla State Med Assoc. 2007 Nov;100(11):417-24. Review.

PMID:
18183858
6.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
7.

Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe.

van de Vijver DA, Derdelinckx I, Boucher CA.

J Infect Dis. 2009 May 1;199(9):1310-7. doi: 10.1086/597804.

PMID:
19301982
8.
9.

Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.

Vyas TK, Shah L, Amiji MM.

Expert Opin Drug Deliv. 2006 Sep;3(5):613-28. Review.

PMID:
16948557
10.

Antiviral drugs in the treatment of AIDS: what is in the pipeline ?

Stellbrink HJ.

Eur J Med Res. 2007 Oct 15;12(9):483-95. Review.

PMID:
17933730
11.

[Resistance tests to improve therapy. More specific use of AIDS drugs].

Paukstadt W.

MMW Fortschr Med. 1999 Sep 16;141(37):18. German. No abstract available.

PMID:
10897968
12.

Combining drug and immune therapy: a potential solution to drug resistance and challenges of HIV vaccines?

Endsley AN, Salama NN, Ho RJ.

Curr HIV Res. 2008 Sep;6(5):401-10. Review.

PMID:
18855650
13.

[Revolutionizing HIV-therapy by Tre-Recombinase? Initial observations and current state of development].

Hauber J, Hauber I, Buchholz F.

MMW Fortschr Med. 2013 Jun 13;155 Suppl 1:22-3. German. No abstract available.

PMID:
23961648
14.

The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies.

Dhami H, Fritz CE, Gankin B, Pak SH, Yi W, Seya MJ, Raffa RB, Nagar S.

J Clin Pharm Ther. 2009 Apr;34(2):147-60. doi: 10.1111/j.1365-2710.2008.00978.x. Review.

PMID:
19250135
15.

How AIDS funding strengthens health systems: progress in pharmaceutical management.

Embrey M, Hoos D, Quick J.

J Acquir Immune Defic Syndr. 2009 Nov;52 Suppl 1:S34-7. doi: 10.1097/QAI.0b013e3181bbca06. Review.

PMID:
19858936
16.

The perverted irony of Health Canada's Special Access Programme.

Christie TK, Montaner JS.

CMAJ. 2006 Jun 6;174(12):1746. No abstract available.

17.

Current clinical treatments of AIDS.

Murphy EM, Jimenez HR, Smith SM.

Adv Pharmacol. 2008;56:27-73. Review. No abstract available.

PMID:
18086408
18.

HIV drug program likely to miss 2005 target.

[No authors listed]

Nat Med. 2005 Mar;11(3):241. No abstract available.

PMID:
15746927
19.

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

De Clercq E.

Int J Antimicrob Agents. 2009 Apr;33(4):307-20. doi: 10.1016/j.ijantimicag.2008.10.010. Epub 2008 Dec 23. Review.

PMID:
19108994
20.

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study.

Cozzi-Lepri A, Phillips AN, Clotet B, Mocroft A, Ruiz L, Kirk O, Lazzarin A, Wiercinska-Drapalo A, Karlsson A, Lundgren JD; EuroSIDA Study Group.

AIDS. 2008 Oct 18;22(16):2187-98. doi: 10.1097/QAD.0b013e328310e04f.

PMID:
18832882

Supplemental Content

Support Center